Quote For RXi Pharmaceuticals Corporation RXII.O
RXi Pharmaceuticals Corporation (RXII.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector: Healthcare ·
industry: Biotechnology ·
$2.13
27 Nov 2009
-4.91%
$2.24
$2.15
51,302
$2.20
$2.11
$9.50
$1.51
0.39
30,924
News
No news stories for this company within the last 30 days.
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Hillsberg, Sanford | Chairman of the Board | -- |
| Beerman, Noah | President, Chief Executive Officer, Director | -- |
| Andrikopoulos, Konstantinos | Vice President, Legal Counsel, Chief Intellectual Property Counsel | -- |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $34.52 |
| Shares Outstanding (Mil.) | 16.21 |
| Float (Mil.) | 16.00 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 7.16 |
| Current Ratio | 2.51 |
| LT Debt/Equity | 0.34 |
| Total Debt/Equity | 0.78 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | -- |
| Price/Book(TTM) | 9.13 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-1.21 |
| Sales(TTM) | $0.00 |
| Book Value(MRQ) | $0.23 |
| Cash Flow(TTM) | $-1.20 |
| Cash(MRQ) | $0.32 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -190.09 |
| Return on Assets(TTM) | -159.10 |
| Return on Investment(TTM) | -189.97 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | -- |
| Operating Margin(TTM) % | -- |
| Profit Margin(TTM) % | -- |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
